Compare Stocks
Compare up to four stocks to (EXAS) by adding the symbol or company name.
EXAS
Compare up to three stocks to EXAS by adding the symbol or company name. | Add Stock | Add Stock | Add Stock |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
Market Value | Market Value 9.99B | Market Value -- | Market Value -- | Market Value -- |
Enterprise Value | EV 12.88B | EV -- | EV -- | EV -- |
Price to Earnings | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- |
Diluted Earnings Per Share | Diluted EPS TTM -1.31 | Diluted EPS TTM -- | Diluted EPS TTM -- | Diluted EPS TTM -- |
Forward Dividend & Yield | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- |
Sector | Sector Healthcare | Sector -- | Sector -- | Sector -- |
Industry | Industry Diagnostics & Research | Industry -- | Industry -- | Industry -- |
CEO | CEO Mr. Kevin T. Conroy | CEO -- | CEO -- | CEO -- |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
1 Week | 1 Week -9.77% | 1 Week -- | 1 Week -- | 1 Week -- |
3 Months | 3 Months -11.20% | 3 Months -- | 3 Months -- | 3 Months -- |
YTD | YTD -26.80% | YTD -- | YTD -- | YTD -- |
1 Year | 1 Year -21.01% | 1 Year -- | 1 Year -- | 1 Year -- |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
Revenue | Revenue 2.53B | Revenue -- | Revenue -- | Revenue -- |
Operating Expenses | Operating Expenses 2.11B | Operating Expenses -- | Operating Expenses -- | Operating Expenses -- |
Operating Income | Operating Income -239.51M | Operating Income -- | Operating Income -- | Operating Income -- |
Revenue Growth YoY | Rev Gr 1Y 5.82% | Rev Gr 1Y -- | Rev Gr 1Y -- | Rev Gr 1Y -- |
Gross Profit | Gross Profit 1.87B | Gross Profit -- | Gross Profit -- | Gross Profit -- |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
Inventory | Inventory 128.53M | Inventory -- | Inventory -- | Inventory -- |
Account Receivables Turnover | A/R Turnover 11.96 | A/R Turnover -- | A/R Turnover -- | A/R Turnover -- |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
Cash Flow from Operations | CF from Ops 112.02M | CF from Ops -- | CF from Ops -- | CF from Ops -- |
Capital Expenditures | CapEx -132.48M | CapEx -- | CapEx -- | CapEx -- |
Cash from Investing Activities | CFI -204.70M | CFI -- | CFI -- | CFI -- |
Free Cash Flow | Free Cash Flow -20.46M | Free Cash Flow -- | Free Cash Flow -- | Free Cash Flow -- |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
Price to Earnings Per Share | P/E -- | P/E -- | P/E -- | P/E -- |
Forward Price to Earnings Per Share | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- |
Price to Free Cash Flow Per Share | P/FCF 626.48 | P/FCF -- | P/FCF -- | P/FCF -- |
Price to Book Value Per Share | P/BV 3.49 | P/BV -- | P/BV -- | P/BV -- |
Price to Sales Ratio | P/S 4.25 | P/S -- | P/S -- | P/S -- |
EV/EBITDA | EV/EBITDA 1,275.02 | EV/EBITDA -- | EV/EBITDA -- | EV/EBITDA -- |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
Operating Margin | Oper. Margin -9.45% | Oper. Margin -- | Oper. Margin -- | Oper. Margin -- |
Gross Margin | Gross Margin 73.67% | Gross Margin -- | Gross Margin -- | Gross Margin -- |
Profit Margin | Profit Margin -9.48% | Profit Margin -- | Profit Margin -- | Profit Margin -- |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
Basic Earnings Per Share | EPS -1.31 | EPS -- | EPS -- | EPS -- |
EPS 1Yr Growth | EPS 1Yr Growth 0.00% | EPS 1Yr Growth -- | EPS 1Yr Growth -- | EPS 1Yr Growth -- |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
Return on Assets | Return on Assets -3.79% | Return on Assets -- | Return on Assets -- | Return on Assets -- |
Return on Capital | Return on Capital -4.25% | Return on Capital -- | Return on Capital -- | Return on Capital -- |
As of May 09, 2024 | EXAS Exact Sciences Corporation | -- | -- | -- |
---|---|---|---|---|
Institutional Ownership % | Inst. Own. % 84.63% | Inst. Own. % -- | Inst. Own. % -- | Inst. Own. % -- |